Status:
UNKNOWN
Vaginal Misoprostol to Improve the Neonatal Respiratory Outcome
Lead Sponsor:
Assiut University
Conditions:
Neonatal Respiratory Distress
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Project summary: Objective: To test the hypothesis that administration of vaginal Misoprostol before elective cesarean section will improve the neonatal respiratory outcomes in late preterm and early...
Detailed Description
Methodology: After a written informed consent obtained, women who are fitting the inclusion criteria will be randomly allocated using sealed, coded, opaque and sequentially numbered envelopes containi...
Eligibility Criteria
Inclusion
- All pregnant women who are planned for elective (planned\& pre labor) cesarean section at 34 -37 weeks gestation.
Exclusion
- Pregnancies with known fetal malformation/s or chromosomal aberrations.
- Presence of absolute contraindication for use of misoprostol.(i.e known hypersensitivity to the drug)
- Women before 34 and after 37 weeks gestation .
- Non reassuring cardiotocogram immediately before recruitment.
- multiple pregnancies.
Key Trial Info
Start Date :
June 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2018
Estimated Enrollment :
292 Patients enrolled
Trial Details
Trial ID
NCT03239327
Start Date
June 1 2016
End Date
January 1 2018
Last Update
January 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
women health center,Assiut university
Asyut, Egypt